BrainTale receives cash injection November 11, 2020 -- Medical device and software developer BrainTale has raised more than one million euros in its first financing round.
European group seeks to create quality 3D-printed PPE November 9, 2020 -- A group of European organizations has banded together to design high-quality 3D-printed personal protective equipment (PPE) that meets standards set by the European Union, according to a 3D Printing Media Network news story.
Dutch group makes use of 3D printing to study bacteria November 2, 2020 -- Leiden University researchers have used 3D printing to produce complex microswimmers and other complex structures that assist with the study of bacteria in water, according to an article posted on 2 November by 3D Printing Industry.
Dutch use molecular scan to find new salivary glands October 30, 2020 -- A group from the Netherlands Cancer Institute in Amsterdam has used PET/CT with a radiopharmaceutical based on a prostate-specific membrane antigen to discover a pair of salivary glands. Sparing these glands during radiation therapy may prevent treatment side effects and improve quality of life for head and neck cancer patients. Discuss
MIM Software receives CE Mark for SPECT software October 21, 2020 -- Medical imaging software developer MIM Software announced it has received the CE Mark for its quantitative SPECT reconstruction software SPECTRA Quant and vendor-neutral SPECT reconstruction method SPECTRA Recon.
Lessons from COVID-19 front line: What can we learn? October 20, 2020 -- Gaining a more complete knowledge of COVID-19 and the value of imaging in these cases -- along with the need to reorganize services, protect staff, and cope with the impact on non-COVID-19 pathologies -- are among the main lessons radiology must learn during the pandemic, according to a senior French radiologist. Discuss
New research highlights progress in residual breast cancer October 20, 2020 -- Image-guided biopsy of the tumor bed or residual abnormalities found on imaging after neoadjuvant chemotherapy is gaining popularity as a predictive tool for assessing residual cancer. The technique can help to identify exceptional treatment responders for de-escalation of local therapy, an international study has found. Discuss